FDA Inspection 1067030 — Ascent Pharmaceuticals Inc
The FDA completed an inspection of Ascent Pharmaceuticals Inc on Jul 27, 2018 in Central Islip, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 27, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Central Islip, NY (United States)
Additional details
Bioanalytical BA/BE